Literature DB >> 8851171

Stimulation of mucin biosynthesis in rat gastric mucosa by FRG-8813 and its structural analogs.

T Ichikawa1, K Ishihara, M Shibata, T Yamaura, K Saigenji, K Hotta.   

Abstract

Certain chemical properties, which may determine the stimulatory actions of the new histamine H2 receptor antagonist, FRG-8813 (2-(furfurylsulfinyl)-N-(4-[4-(piperidinomethyl)-2-pyridyl]o xy-(Z)- 2-butenyl)acetamide), on mucin biosynthesis, were identified by considering the derivation of this drug using an organ culture system of the rat stomach. [3H]Glucosamine and [35S]sulfate incorporation was stimulated in the corpus region by FRG-8813 and its structural analog, compound A (N-[4-[[4- (piperidinylmethyl)pyridyl]-2-oxy]-(Z)-2-butenyl]phthalimide). The chronotropic response to histamine in the guinea pig right atria was suppressed by FRG-8813 in a concentration-dependent fashion. In contrast, compound A did not suppress the histamine-induced response. Ranitidine at 10(-4) M did not suppress the FRG-8813-induced increase in [3H]glucosamine incorporation into mucin. These results suggest that the pyridine derivative and amide structure are chemically important in FRG-8813 as a stimulant on mucus metabolism. Also, this effect is not directly due to histamine H2 receptor antagonism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851171     DOI: 10.1016/0014-2999(95)00731-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa.

Authors:  T Ichikawa; K Ishihara; H Hayashida; H Hiruma; K Saigenji; K Hotta
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

2.  Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis.

Authors:  Yoichi Saegusa; Takafumi Ichikawa; Tomohisa Iwai; Yukinobu Goso; Tomoaki Ikezawa; Motoko Nakano; Nobuaki Shikama; Katsunori Saigenji; Kazuhiko Ishihara
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.